Erschienen in:
01.06.2011 | Letter
Which is the most effective strategy: early detection of coagulopathy with thromboelastometry or use of hemostatic factors or both?
verfasst von:
Jean-Stephane David, Virginie Marchal, Albrice Levrat, Kenji Inaba
Erschienen in:
Critical Care
|
Ausgabe 3/2011
Einloggen, um Zugang zu erhalten
Excerpt
In an article in the previous issue of
Critical Care, Schöchl and colleagues suggested that, in trauma patients, a hemostatic strategy combining the use of fibrinogen concentrates or prothrombin complex concentrates (PCCs) (or both) guided by thromboelastometry resulted in a reduction of exposure to allogeneic blood products when compared with a strategy using fresh frozen plasma (FFP) guided by standard coagulation assays [
1]. The primary concern with this analysis is the comparison of a series of patients treated at a single center with a highly protocolized approach to transfusion against a registry-based cohort of patients from multiple centers with no standardized protocol. Also, several very specific biases introduced into the analysis are of concern. First, the time required to obtain a hemostatic result varied greatly between groups, ranging from less than 15 minutes with the rotation thrombelastography (ROTEM) to usually more than 45 to 60 minutes in the standard group [
2]. The timing of coagulation component replacement must be factored into this analysis. The second bias centers around the concentration of fibrinogen delivered: 3 g of fibrinogen (median of 6 units of FFP) in the FFP group versus a median of 6 g in the fibrinogen-PCC group. Previous reports have demonstrated a close relationship between blood loss and fibrinogen level [
3,
4]. …